Montara Therapeutics adds $20M to seed fundraise for neurology pipeline
Montara Therapeutics has raised $20 million in an expanded seed financing to advance a pipeline of preclinical CNS candidates that it says could address safety concerns that have hampered R&D efforts to date. The latest ...
